Expertise in
2
conditions

Dashiell C. Gantner

553 St Kilda Rd, 
Melbourne, VIC, AU 
Expertise in
2
conditions
553 St Kilda Rd, 
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Dashiell Gantner practices in Melbourne, Australia. Mr. Gantner is highly rated in 2 conditions, according to our data. His top areas of expertise are Traumatic Brain Injury, Increased Intracranial Pressure, Subdural Hematoma, Metabolic Acidosis, and Craniectomy.

His clinical research consists of co-authoring 43 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

553 St Kilda Rd, Melbourne, VIC 3004, Australia
Other Locations
Commercial Road, Melbourne, VIC 3004, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
Enrollment Status: Completed
Publish Date: October 18, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Multi-centre Randomised, Double-blinded, Placebo-controlled Trial of Pre-hospital Treatment With Tranexamic Acid for Severely Injured Patients at Risk of Acute Traumatic Coagulopathy.
A Multi-centre Randomised, Double-blinded, Placebo-controlled Trial of Pre-hospital Treatment With Tranexamic Acid for Severely Injured Patients at Risk of Acute Traumatic Coagulopathy.
Enrollment Status: Completed
Publish Date: January 27, 2023
Intervention Type: Drug
Study Drug: Tranexamic Acid
Study Phase: Phase 3
View 1 Less Clinical Trial

43 Total Publications

Tranexamic acid did not attenuate the acute rise in plasma syndecan-1 in a severely injured cohort: a laboratory analysis of the PATCH clinical trial.
Tranexamic acid did not attenuate the acute rise in plasma syndecan-1 in a severely injured cohort: a laboratory analysis of the PATCH clinical trial.
Journal: Intensive care medicine experimental
Published: April 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gantner's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile